Essential Guide azelaic acid

Applications / Hair-growth & regrowth

Spironolactone Spironolactone is a potassium-sparing diuretic that prevents from absorbing too much salt and keeps the potassium levels from getting too low. It is also used for the treatment of acne, hirsutism and androgenic alopecia. Spironolactone is for females what finasteride is for males.

The efficacy of spironolactone is rather limited indeed, and hair regrowth is merely a side effect of the diuretic activity. The side effects may be quite sincere indeed. The product shall by no means be part of personal care and cosmetic products and medical devices. Spironolactone is also used to treat certain types of acne, hirsutism (excessive hair growth), and polycystic ovary syndrome (PCOS). In these cases, it works by blocking the action of androgens, hormones that can cause acne and excessive hair growth. By blocking the action of androgens, spironolactone can help to reduce acne and hair growth. Botanical products There are not too many cosmetically allowed products that inhibit 5- α -reductase; saw palmetto (INCI: Sabal Serrulata/Serenoa Repens) is an example. The applicable part of saw palmetto is the ripe fruit. The lipid fraction of the volatile oil and fatty oils contains constituents active in treating benign prostatic hyperplasia (BPH), for which saw palmetto is recommended. Saw palmetto has a proven positive track record for hair (re)growth preparations because of its potential to inhibit 5- α -reductase. Saw palmetto also hides a significant content of phytosterols (ß-sitosterol, stigmasterol, lupeol, lupenone and cycloartenol). Some other botanical products are also claimed to inhibit 5- α -reductase, but there is insufficient proof of their activity. Examples are Ganoderma lucidum (reishi mushroom), that lives on the oil palm (Elaeis guineensis); ganoderic acid and ganoderol B are believed to be the active species.

Phone : +31 475 20 60 70 • service@azeco-cosmeceuticals.com • www.azeco-cosmeceuticals.com

26

Made with FlippingBook Annual report